跳至主要内容
临床试验/NL-OMON52766
NL-OMON52766已完成不适用

MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with Polycystic Ovary Syndrome: a multicentre double-blind randomised controlled trial - MYPP-trial

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 464 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
464

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • - >= 18 years of age
  • - Diagnosis of PCOS according to the Rotterdam consensus criteria and confirmed
  • by a gynaecologist
  • - A viable singleton pregnancy confirmed by ultrasound
  • - Being able to initiate the use of study supplements between 8+0 and 16+0
  • weeks gestational age
  • - Ability to understand Dutch or English
  • - Ability to provide written informed consent

排除标准

  • - Diagnosis of pre-existent type-1 or 2 diabetes mellitus
  • - Pre-existent renal failure, defined as an estimated glomerular filtration
  • rate (eGFR) less than 50 ml/min/1.73m2
  • - Use of myo-inositol supplements, other insulin-mimetics, hypoglycaemic agents
  • (e.g. metformin) and/or systemic steroids, that cannot be discontinued at the
  • time of inclusion

研究者

相似试验